Skip to content

Percutaneous Unilateral Biportal Endoscopy Versus Uniportal Endoscopy for Lumbar Spinal Stenosis: Study Protocol

Percutaneous Unilateral Biportal Endoscopy Versus Uniportal Endoscopy for Lumbar Spinal Stenosis: a Single-center, Prospective, Non-randomized Cohort Trial Protocol

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06365229
Enrollment
120
Registered
2024-04-15
Start date
2023-01-01
Completion date
2024-12-31
Last updated
2025-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spinal Stenosis

Brief summary

A prospective study aimed to compare the efficacy and safety of Unilateral biportal endoscopic (UBE) technique and uniportal endoscopic (UE) technique for treating patients with lumbar spinal stenosis (LSS).

Interventions

None listed

Sponsors

Beijing Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years

Inclusion criteria

* Age range: 50-80 years * Diagnosed with LSS of 1-2 response levels * The predominant manifestation is neurogenic intermittent claudication, and conservative treatment has been ineffective for at least 3 months * Degenerative lumbar spondylolisthesis of less than I degree or without spine instability * Patients agree to participate in the study and are willing to complete the follow-up

Exclusion criteria

* Isthmic lumbar spondylolisthesis or degenerative lumbar spondylolisthesis of greater than I degree * Instability at the response level * Prior surgical history at the response level * Scoliosis with Cobb angle >20 degrees * Other conditions affecting the lumbar spine (infection, tumor, fracture, neurological diseases, and others) * Patients with medical disorders who are unable to tolerate surgery

Design outcomes

Primary

MeasureTime frameDescription
Oswestry Disability Index (ODI)From enrollment to the end of follow-up at 1 year0-100%, the higher the score, the more severe the lumbar spine dysfunction

Secondary

MeasureTime frameDescription
Computed tomography (CT) scansFrom enrollment to the end of follow-up at 2 weeksbony decompression range; preservation rate of the facet joint
Creatine kinase (CK)From enrollment to the end of follow-up at 2 weeks
Erythrocyte sedimentation rate (ESR)From enrollment to the follow-up at 2 weeks
Surgical complicationFrom enrollment to the end of follow-up at 1 yearAdverse events will be recorded to assess the safety of decompression using UBE or UE for LSS.
VAS (visual analogue scale) for leg painFrom enrollment to the end of follow-up at 1 year0-10, the higher the score, the more severe the pain
VAS (visual analogue scale) for lower back painFrom enrollment to the end of follow-up at 1 year0-10, the higher the score, the more severe the pain
Japanese Orthopaedic Association (JOA) scoreFrom enrollment to the end of follow-up at 1 year0-29, the higher the score, the better the lumbar spine function
Modified MacNab criteriaFrom enrollment to the end of follow-up at 1 yearAccording to satisfaction, it is divided into four levels: excellent, good, acceptable, and poorexcellent, good, fair, and poor
Operation timeImmediately after the surgery
Blood lossImmediately after the surgery
Postoperative hospital staysImmediately after the discharge
Magnetic resonance imaging (MRI)From enrollment to the follow-up at 2 weeksEnlargement ratio of the dural sac
GenderBaseline, pre-surgery
Body mass index (BMI)Baseline, pre-surgery
Medical comorbidityBaseline, pre-surgery
Smoking statusBaseline, pre-surgery
Alcohol statusBaseline, pre-surgery
Symptoms durationBaseline, pre-surgery
Physical examination findingBaseline, pre-surgery
Previous spinal surgeryBaseline, pre-surgery
Affected levelBaseline, pre-surgery
Stenosis gradeBaseline, pre-surgery
Physical-component summary score of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)From enrollment to the end of follow-up at 1 yearrange, 0-100 points, with higher scores indicating better physical health-related quality of life
AgeBaseline, pre-surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026